Association of P53 Arg72Pro polymorphism and Helicobacter pylori infection with risk of gastric cancer in a high incidence area in China

World Chinese Journal of Digestology

Volumn 17, Issue 36, 2009, Pages 3734-3739

  Zhu, Ke Xiang ^a   Li, Yu Min ^a   Li, Xun ^a   Zhou, Wen Ce ^a   Shan, Yong ^b   Liu, Tao ^a   He, Wen Ting ^a  

^a LANZHOU UNIVERSITY   (China)

^b Department of General Surgery   (China)

Author keywords

Gastric cancer; Helicobacter pylori; P53; Polymorphism

Indexed keywords

GENOMIC DNA; PROTEIN P53;

ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER RISK; CHINA; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HELICOBACTER INFECTION; HIGH RISK POPULATION; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; REAL TIME POLYMERASE CHAIN REACTION; SMOKING; STAINING; STOMACH CANCER;

EID: 75149158391     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v17.i36.3734     Document Type: Article

References (21)

1. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006; 12: 17-20
2. Shepherd T, Tolbert D, Benedetti J, Macdonald J, Stemmermann G, Wiest J, DeVoe G, Miller MA, Wang J, Noffsinger A, Fenoglio-Preiser C. Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology 2000; 118: 1039-1044
3. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2: 28-37
4. Konturek PC, Konturek SJ, Brzozowski T. Gastric cancer and Helicobacter pylori infection. J Physiol Pharmacol 2006; 57 Suppl 3: 51-65
5. Azuma T, Ohtani M, Yamazaki Y, Higashi H, Hatakeyama M. Meta-analysis of the relationship between CagA seropositivity and gastric cancer. Gastroenterology 2004; 126: 1926-1927; author reply 1927-1928
6. Poddar U, Yachha SK. Helicobacter pylori in children: an Indian perspective. Indian Pediatr 2007; 44: 761-770
7. Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003; 125: 1636-1644
8. Segal F, Kaspary AP, Prolla JC, Leistner S. p53 protein overexpression and p53 mutation analysis in patients with intestinal metaplasia of the cardia and Barrett's esophagus. Cancer Lett 2004; 210: 213-218
9. Villunger A, Michalak EM, Coultas L, Müllauer F, Böck G, Ausserlechner MJ, Adams JM, Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 2003; 302: 1036-1038
10. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV. Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 1987; 7: 961-963
11. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999; 19: 1092-1100
12. Chung WC, Lee KM, Lee BI, Chun JS, Lee SY, Chang UI, Park SH, Yang JM, Choi KY, Chung IS. P53 genetic polymorphism of gastric cancer in Korea. Korean J Intern Med 2006; 21: 28-32
13. Pérez-Pérez GI, Bosques-Padilla FJ, Crosatti ML, Tijerina-Menchaca R, Garza-González E. Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer. Scand J Gastroenterol 2005; 40: 56-60
14. Chinese source
15. Chinese source
16. Mahaffey D, Yoo Y, Rechsteiner M. Ubiquitin metabolism in cycling Xenopus egg extracts. J Biol Chem 1993; 268: 21205-21211
17. Zhang W, Hu G, Deisseroth A. Polymorphism at codon 72 of the p53 gene in human acut e myelogenous leukemia. Gene 1992; 117: 271-275
18. Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA, James N, McGregor JM, Harwood CA, Yulug IG, Vousden KH, Allday MJ, Gusterson B, Ikawa S, Hinds PW, Crook T, Kaelin WG Jr. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet 2000; 25: 47-54
19. Ierardi E, Francavi l la R, Panel la C. Ef fect of Helicobacter pylori eradication on intestinal metaplasia and gastric epithelium proliferation. Ital J Gastroenterol Hepatol 1997; 29: 470-475
20. Chinese source
21. Chinese source